Navigation Links
Timothy T. Goodnow, Ph.D., Joins Sensors for Medicine and Science, Inc. Board of Directors
Date:11/8/2010

GERMANTOWN, Md., Nov. 8, 2010 /PRNewswire-USNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced that Tim Goodnow, Ph.D., will be joining the Board of Directors and working with the Company as a Consultant.

Dr. Goodnow was most recently with Abbott Diabetes Care where he was the Vice President, Technical Operations.  Prior to that, he held positions at TheraSense, Verax Biomedical, Dade Behring and Baxter Healthcare.  Dr. Goodnow has led the successful development of a number of FDA approved glucose monitoring systems.  He holds a Ph.D. and B.S. in Chemistry from the University of Miami.

"I am thrilled to be joining the Sensors for Medicine and Science Board of Directors," said Dr. Goodnow.  "I look forward to working with the team to successfully launch these innovative new devices and am excited about the improvements they can make for people with diabetes."

"Tim is a great addition to our Board," stated Stephen P. DeFalco, Executive Chairman.  "His experience and track record bringing innovative glucose monitoring devices to market will help accelerate our efforts."

Sensors for Medicine and Science's lead product is a long-term, implanted continuous glucose monitor based on its unique and proprietary sensor technology.  This product includes a miniaturized sensor and an external reader.  The sensor is inductively powered and remotely interrogated, so there is no battery on-board and no wires connecting the implanted sensor to the external reader.  As a result, after implantation, the sensor functions noninvasively, painlessly, automatically, and continuously.  The Company is also developing a version of the technology to support efforts for glycemic control of patients in an Intensive Care Unit setting.

About Sensors for Medicine and Science, Inc.

Sensors for Medicine and Science, Inc. is pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes.  The Company believes that its long-term, continuous glucose monitor technology has the potential to replace regular finger stick monitoring.  

Sensors for Medicine and Science, Inc. has also developed oxygen sensor technology, with potential applications in areas such as metabolic monitoring (weight management), respiratory and cardiac disease.  In addition, the Company sells its oxygen sensors as a component to original equipment manufacturers.

For more information about Sensors for Medicine and Science, Inc., please visit http://www.s4ms.com.


'/>"/>
SOURCE Sensors for Medicine and Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care
2. HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
3. Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
4. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
5. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
6. CORD:USE Cord Blood Bank Congratulates Team Member Hal Broxmeyer, Ph.D., on his Election as President of the American Society of Hematology
7. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
8. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
9. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
10. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
11. Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
Breaking Medicine News(10 mins):